News

Columnist Shalom Lim will continue to pursue the themes that matter to him as a person with Duchenne MD, but as a writer now, ...
Preliminary data are expected this year for a Phase 1/2 clinical trial testing the investigational therapy SRP-1003 in DM1.
Agamree, an approved steroid treatment for Duchenne MD, will be sold in Turkey by GEN, per an agreement with Santhera.
Enrollment is now ongoing in a first-in-human clinical trial testing EPI-321, a therapy designed to target the underlying ...
A protein called MYOD has long been known to be able to turn on genes, but a recent study has found that it also can turn off ...
Columnist Robin Stemple, his brothers, and more enjoy a long-in-the works family music celebration at his mother's nursing home.
In both good times and bad, the importance of human connection cannot be understated, columnist Patrick Moeschen writes.
Columnist Shalom Lin and his partner, Amanda — both disabled artists — find that their challenges are exactly what can drive ...
Doctors can use several tests to diagnose muscular dystrophy (MD). A correct diagnosis gives patients an understanding of how their disease is likely to progress. It also helps doctors do a better job ...
There is no cure for muscular dystrophy (MD) yet, but several treatments and therapies are under development to help manage the symptoms, improve patients’ quality of life, and even treat the ...
Muscular dystrophy refers to a group of genetic diseases that cause progressive muscle weakness and loss. There are more than 30 types of muscular dystrophy, all with different causes and symptoms.